These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35986104)
1. Quantitative and rapid detection of morphine and hydromorphone at the point of care by an automated giant magnetoresistive nanosensor platform. Cortade DL; Wang SX Anal Bioanal Chem; 2022 Oct; 414(24):7211-7221. PubMed ID: 35986104 [TBL] [Abstract][Full Text] [Related]
2. From saliva to SNP: non-invasive, point-of-care genotyping for precision medicine applications using recombinase polymerase amplification and giant magnetoresistive nanosensors. de Olazarra AS; Cortade DL; Wang SX Lab Chip; 2022 May; 22(11):2131-2144. PubMed ID: 35537344 [TBL] [Abstract][Full Text] [Related]
3. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. Collins JJ; Geake J; Grier HE; Houck CS; Thaler HT; Weinstein HJ; Twum-Danso NY; Berde CB J Pediatr; 1996 Nov; 129(5):722-8. PubMed ID: 8917240 [TBL] [Abstract][Full Text] [Related]
4. Rapid, Point-of-Care Host-Based Gene Expression Diagnostics Using Giant Magnetoresistive Biosensors. Sofia de Olazarra A; Chen FE; Wang TH; Wang SX ACS Sens; 2023 Jul; 8(7):2780-2790. PubMed ID: 37368357 [TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
6. Magneto-nanosensor smartphone platform for the detection of HIV and leukocytosis at point-of-care. Ng E; Yao C; Shultz TO; Ross-Howe S; Wang SX Nanomedicine; 2019 Feb; 16():10-19. PubMed ID: 30502420 [TBL] [Abstract][Full Text] [Related]
7. Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. Cone EJ; Heit HA; Caplan YH; Gourlay D J Anal Toxicol; 2006; 30(1):1-5. PubMed ID: 16620524 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial. Chang AK; Bijur PE; Baccelieri A; Gallagher EJ Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study. Clemens KE; Klaschik E Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302 [TBL] [Abstract][Full Text] [Related]
10. The detection of hydromorphone in urine specimens with high morphine concentrations. McDonough PC; Levine B; Vorce S; Jufer RA; Fowler D J Forensic Sci; 2008 May; 53(3):752-4. PubMed ID: 18471228 [TBL] [Abstract][Full Text] [Related]
11. Resolution of Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid Rotation to Fentanyl: A Case Series. Veizi E; Tornero-Bold M; Hayek SM Pain Pract; 2016 Jul; 16(6):E94-8. PubMed ID: 26990069 [TBL] [Abstract][Full Text] [Related]
12. Morphine and hydromorphone-induced hyperalgesia in a hospice patient. Juba KM; Wahler RG; Daron SM J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158 [TBL] [Abstract][Full Text] [Related]
13. Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone. Shanthanna H; Paul J; Lovrics P; Vanniyasingam T; Devereaux PJ; Bhandari M; Thabane L Br J Anaesth; 2019 Jun; 122(6):e107-e113. PubMed ID: 31027915 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Coda BA; O'Sullivan B; Donaldson G; Bohl S; Chapman CR; Shen DD Pain; 1997 Sep; 72(3):333-46. PubMed ID: 9313274 [TBL] [Abstract][Full Text] [Related]
15. Evidence for Neurotoxicity Due to Morphine or Hydromorphone Use in Renal Impairment: A Systematic Review. Lee KA; Ganta N; Horton JR; Chai E J Palliat Med; 2016 Nov; 19(11):1179-1187. PubMed ID: 27399959 [TBL] [Abstract][Full Text] [Related]
16. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine. Beatty NC; Arendt KW; Niesen AD; Wittwer ED; Jacob AK J Clin Anesth; 2013 Aug; 25(5):379-383. PubMed ID: 23965210 [TBL] [Abstract][Full Text] [Related]
17. The side effects of morphine and hydromorphone patient-controlled analgesia. Hong D; Flood P; Diaz G Anesth Analg; 2008 Oct; 107(4):1384-9. PubMed ID: 18806056 [TBL] [Abstract][Full Text] [Related]
18. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone. Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results. Bertholf RL; Johannsen LM; Reisfield GM J Anal Toxicol; 2015; 39(1):24-8. PubMed ID: 25288720 [TBL] [Abstract][Full Text] [Related]
20. Effects of hydromorphone and morphine intravenous analgesia on plasma motilin and postoperative nausea and vomiting in patients undergoing total hysterectomy. Liu Y; Yang L; Tao SJ Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5697-5703. PubMed ID: 30229847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]